← Leaderboards
Douglas W Losordo
Caritas St. Elizabeth'S Medical Center
$24,177,187
Attributed
$24,177,187
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$31,632,154 · 20
By mechanism
P01$17,135,073 · 12
R01$14,497,081 · 8
Top collaborators
No co-investigators on record.
Most similar at Caritas St. Elizabeth'S Medical Center
Same institution · by research overlap
- Kathryn Hirst$203,012,967
Others in their field
Top investigators on “Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$220,248,453
- David Heimbrook · Leidos Biomedical Research, Inc.$161,931,307
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,044,559
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$70,591,644
- Michelle M Le Beau · University Of Chicago$70,506,423
Research focus
Stem CellsCardiovascular SystemCellsVascular Endothelial Growth FactorsTissuesIn VivoLaboratoriesRegenerative MedicineDesignBone MarrowProgramsAngiogenesisResearch StudyIschemiaEndothelial CellsBaseRepairedMediatingBone Marrow TransplantationGene TherapyPhysiologicalResponseIn VitroVascular Endothelium
Grant awards (81)
Epigenetic Modulation of EPC for Cardiomyogenesis$355,353
P01 · FY2015 · HL · contact PI
Role of PAI-1 in Cardiovascular Repair and Fibrosis$350,158
P01 · FY2015 · HL · contact PI
Peptide Amphiphiles to Augment Progentitor Cell Therapies$347,940
P01 · FY2015 · HL · contact PI
Mitochondrial Defects in EPCs in Diabetes and Aging$347,811
P01 · FY2015 · HL · contact PI
FACS Analysis and Cell Sorting$207,303
P01 · FY2015 · HL · contact PI
Small Animal Surgery and Histology$201,879
P01 · FY2015 · HL · contact PI
Advanced Molecular Imaging$172,431
P01 · FY2015 · HL · contact PI
Administrative Core$80,283
P01 · FY2015 · HL · contact PI
Epigenetic Modulation of EPC for Cardiomyogenesis$359,824
P01 · FY2014 · HL · contact PI
Role of PAI-1 in Cardiovascular Repair and Fibrosis$356,029
P01 · FY2014 · HL · contact PI
Peptide Amphiphiles to Augment Progentitor Cell Therapies$354,400
P01 · FY2014 · HL · contact PI
Mitochondrial Defects in EPCs in Diabetes and Aging$354,046
P01 · FY2014 · HL · contact PI
FACS Analysis and Cell Sorting$211,812
P01 · FY2014 · HL · contact PI
Small Animal Surgery and Histology$207,849
P01 · FY2014 · HL · contact PI
Advanced Molecular Imaging$177,444
P01 · FY2014 · HL · contact PI
Administrative Core$85,146
P01 · FY2014 · HL · contact PI
Epigenetic Modulation of EPC for Cardiomyogenesis$344,554
P01 · FY2013 · HL · contact PI
Role of PAI-1 in Cardiovascular Repair and Fibrosis$342,135
P01 · FY2013 · HL · contact PI
Peptide Amphiphiles to Augment Progentitor Cell Therapies$341,102
P01 · FY2013 · HL · contact PI
Mitochondrial Defects in EPCs in Diabetes and Aging$340,514
P01 · FY2013 · HL · contact PI
FACS Analysis and Cell Sorting$197,904
P01 · FY2013 · HL · contact PI
Small Animal Surgery and Histology$195,379
P01 · FY2013 · HL · contact PI
Advanced Molecular Imaging$164,325
P01 · FY2013 · HL · contact PI
Administrative Core$72,702
P01 · FY2013 · HL · contact PI
Mitochondrial Defects in EPCs in Diabetes and Aging$365,756
P01 · FY2012 · HL · contact PI
Epigenetic Modulation of EPC for Cardiomyogenesis$364,978
P01 · FY2012 · HL · contact PI
Role of PAI-1 in Cardiovascular Repair and Fibrosis$363,786
P01 · FY2012 · HL · contact PI
Peptide Amphiphiles to Augment Progentitor Cell Therapies$363,278
P01 · FY2012 · HL · contact PI
FACS Analysis and Cell Sorting$215,356
P01 · FY2012 · HL · contact PI
Small Animal Surgery and Histology$214,114
P01 · FY2012 · HL · contact PI
Advanced Molecular Imaging$181,548
P01 · FY2012 · HL · contact PI
Administrative Core$87,910
P01 · FY2012 · HL · contact PI
Cardiovascular Regenerative Medicine$2,285,071
P01 · FY2011 · HL · contact PI
Peptide Amphiphiles to Augment Progentitor Cell Therapies$381,250
P01 · FY2011 · HL · contact PI
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PAD$330,725
R01 · FY2011 · HL · contact PI
Administrative Core$99,125
P01 · FY2011 · HL · contact PI
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PAD$543,964
R01 · FY2010 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine III$455,842
R01 · FY2010 · HL · contact PI
Novel approaches to ischemic tissue repair$381,250
R01 · FY2010 · HL · contact PI
Role of Progenitor Cells in Cardiovascular Medicine$366,553
R01 · FY2010 · HL · contact PI
Therapeutic Angiogenesis in Vascular Medicine III$457,500
R01 · FY2009 · HL · contact PI
Novel approaches to ischemic tissue repair$381,250
R01 · FY2009 · HL · contact PI
Role of Progenitor Cells in Cardiovascular Medicine$366,553
R01 · FY2009 · HL · contact PI
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PAD$529,972
R01 · FY2008 · HL · contact PI
Role of Progenitor Cells in Cardiovascular Medicine$366,553
R01 · FY2008 · HL · contact PI
Progenitor Cells in Vascular Biology$357,938
R01 · FY2008 · HL · contact PI
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PAD$526,922
R01 · FY2007 · HL · contact PI
Role of Progenitor Cells in Cardiovascular Medicine$366,553
R01 · FY2007 · HL · contact PI
Progenitor Cells in Vascular Biology$357,938
R01 · FY2007 · HL · contact PI
Restenosis and Endothelial Proliferation$354,556
R01 · FY2007 · HL · contact PI
Autologous CD34+ Cell Therapy for Therapeutic Angiogenesis in Advanced PAD$570,336
R01 · FY2006 · HL · contact PI
Role of Progenitor Cells in Cardiovascular Medicine$425,000
R01 · FY2006 · HL · contact PI
Progenitor Cells in Vascular Biology$402,806
R01 · FY2006 · HL · contact PI
Restenosis and Endothelial Proliferation$384,794
R01 · FY2006 · HL · contact PI
Progenitor Cells in Vascular Biology$412,500
R01 · FY2005 · HL
Restenosis and Endothelial Proliferation$382,581
R01 · FY2005 · HL
Core--Training$228,075
P01 · FY2005 · HL
VEGF gene transfer to prevent coronary artery restenosis$228,075
P01 · FY2005 · HL
Center of Excellence in Gene Therapy(PROGRAM PROJECT)$1,772,957
P01 · FY2004 · HL
ESTROGEN, ANGIOGENESIS AND ENDOTHELIAL PROGENITOR CELLS$416,250
R01 · FY2004 · HL
RE-ENDOTHELIALIZATION AND RESTENOSIS II$383,669
R01 · FY2004 · HL
Restenosis and Endothelial Proliferation$371,437
R01 · FY2004 · HL
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE II$337,329
R01 · FY2004 · HL
Center of Excellence in Gene Therapy(PROGRAM PROJECT)$1,722,809
P01 · FY2003 · HL
ESTROGEN, ANGIOGENESIS AND ENDOTHELIAL PROGENITOR CELLS$416,250
R01 · FY2003 · HL
RE-ENDOTHELIALIZATION AND RESTENOSIS II$372,492
R01 · FY2003 · HL
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE II$327,507
R01 · FY2003 · HL
Center of Excellence in Gene Therapy(PROGRAM PROJECT)$1,674,130
P01 · FY2002 · HL
ESTROGEN, ANGIOGENESIS AND ENDOTHELIAL PROGENITOR CELLS$416,250
R01 · FY2002 · HL
RE-ENDOTHELIALIZATION AND RESTENOSIS II$361,641
R01 · FY2002 · HL
RESTENOSIS AND ENDOTHELIAL PROLIFERATION$359,385
R01 · FY2002 · HL
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE II$317,968
R01 · FY2002 · HL
Core--Training$209,266
P01 · FY2002 · HL
VEGF gene transfer to prevent coronary artery restenosis$209,266
P01 · FY2002 · HL
ESTROGEN, ANGIOGENESIS AND ENDOTHELIAL PROGENITOR CELLS$416,250
R01 · FY2001 · HL
RESTENOSIS AND ENDOTHELIAL PROLIFERATION$352,209
R01 · FY2001 · HL
RE-ENDOTHELIALIZATION AND RESTENOSIS II$351,112
R01 · FY2001 · HL
Core--Training$0
P01 · FY2001 · HL
VEGF gene transfer to prevent coronary artery restenosis$0
P01 · FY2001 · HL
RESTENOSIS AND ENDOTHELIAL PROLIFERATION$341,386
R01 · FY2000 · HL
ESTROGEN FOR PREVENTION OF RESTENOSIS IN OLDER WOMEN$233,860
R01 · FY2000 · AG